BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadaghianloo N, Contenti J, Dardik A, Mazure NM. Role of Hypoxia and Metabolism in the Development of Neointimal Hyperplasia in Arteriovenous Fistulas. Int J Mol Sci 2019;20:E5387. [PMID: 31671790 DOI: 10.3390/ijms20215387] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Ruan L, Yao X, Li W, Zhang L, Yang H, Sun J, Li A. Effect of galectin-3 in the pathogenesis of arteriovenous fistula stenosis formation. Ren Fail 2021;43:566-76. [PMID: 33757402 DOI: 10.1080/0886022X.2021.1902822] [Reference Citation Analysis]
2 Kaller R, Mureșan AV, Arbănași EM, Arbănași EM, Kovács I, Horváth E, Suciu BA, Hosu I, Russu E. Uncommon Surgical Management by AVF between the Great Saphenous Vein and Anterior Tibial Artery for Old Radiocephalic AVF Failure. Life 2022;12:529. [DOI: 10.3390/life12040529] [Reference Citation Analysis]
3 Sadaghianloo N, Contenti J, Declemy S, Ambrosetti D, Zdralevic M, Tannour-Louet M, Fabbri L, Pagès G, Bost F, Hassen-Khodja R, Pouysségur J, Jean-Baptiste E, Dardik A, Mazure NM. Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula. J Physiol 2021;599:2299-321. [PMID: 33608879 DOI: 10.1113/JP281218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Eroglu E, Kocyigit I, Kahriman G, Karakukcu C, Tuncay A, Zararsiz GE, Eren D, Kalay N, Sipahioglu MH, Oymak O, Tokgoz B. Soluble vascular endothelial growth factor receptor-1 as a novel marker of arteriovenous fistula stenosis in hemodialysis patients. Hemodial Int 2021;25:164-72. [PMID: 33155365 DOI: 10.1111/hdi.12903] [Reference Citation Analysis]
5 Huang X, Guan J, Sheng Z, Wang M, Xu T, Guo G, Wan P, Tian B, Zhou J, Huang A, Hao J, Yao L. Effect of local anti-vascular endothelial growth factor therapy to prevent the formation of stenosis in outflow vein in arteriovenous fistula. Journal of Translational Internal Medicine 2021;9:307-17. [DOI: 10.2478/jtim-2021-0045] [Reference Citation Analysis]
6 Chung S, Kim GH. Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside. Life (Basel) 2021;11:389. [PMID: 33923115 DOI: 10.3390/life11050389] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Eroglu E, Kocyiğit I, Karakukcu C, Tuncay A, Zararsiz G, Eren D, Kahriman G, Hayri Sipahioglu M, Tokgoz B, Tasdemir K, Oymak O. Hypoxia-inducible factors in arteriovenous fistula maturation: A prospective cohort study. Eur J Clin Invest 2020;50:e13350. [PMID: 32652532 DOI: 10.1111/eci.13350] [Reference Citation Analysis]
8 Sadaghianloo N, Contenti J, Dufies M, Parola J, Rouleau M, Lee S, Peyron JF, Fabbri L, Hassen-Khodja R, Pouysségur J, Bost F, Jean-Baptiste E, Dardik A, Mazure NM. Co-culture of human fibroblasts, smooth muscle and endothelial cells promotes osteopontin induction in hypoxia. J Cell Mol Med 2020;24:2931-41. [PMID: 32032472 DOI: 10.1111/jcmm.14905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tsai HC, Ou SM, Wu CC, Huang CC, Hsieh JT, Tseng PY, Lee CY, Yang CY, Tarng DC. Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients. Am J Nephrol 2022;53:148-56. [PMID: 35220304 DOI: 10.1159/000522049] [Reference Citation Analysis]